SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 108, Issue 6, 2011, Pages 902-903

Immortal person time bias in pharmacoepidemiological studies of antihypertensive drugs

(2) Assimes, Themistocles L a Suissa, Samy a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST;

CANCER RISK; COMORBIDITY; FOOD AND DRUG ADMINISTRATION; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; LETTER; LUNG CANCER; MORBIDITY; MORTALITY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK REDUCTION; TAIWAN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTENSION; MALE; NEOPLASMS;

EID: 80052285647 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2011.06.031 Document Type: Letter

Times cited : (7)

References (9)

1
- 79952773620
- Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension
- C.C. Huang, W.L. Chan, Y.C. Chen, T.J. Chen, S.J. Lin, J.W. Chen, and H.B. Leu Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension Am J Cardiol 107 2011 1028 1033
- (2011) Am J Cardiol , vol.107 , pp. 1028-1033
- Huang, C.C.¹ Chan, W.L.² Chen, Y.C.³ Chen, T.J.⁴ Lin, S.J.⁵ Chen, J.W.⁶ Leu, H.B.⁷

2
- 77954030665
- Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials
- I. Sipahi, S.M. Debanne, D.Y. Rowland, D.I. Simon, and J.C. Fang Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials Lancet Oncol 11 2010 627 636
- (2010) Lancet Oncol , vol.11 , pp. 627-636
- Sipahi, I.¹ Debanne, S.M.² Rowland, D.Y.³ Simon, D.I.⁴ Fang, J.C.⁵

3
- 33746039654
- Long-term safety of antihypertensive therapy
- DOI 10.1016/j.pcad.2006.06.002, PII S0033062006000661
- E. Grossman, and F.H. Messerli Long-term safety of antihypertensive therapy Prog Cardiovasc Dis 49 2006 16 25 (Pubitemid 44080802)
- (2006) Progress in Cardiovascular Diseases , vol.49 , Issue.1 , pp. 16-25
- Grossman, E.¹ Messerli, F.H.²

4
- 80052276385
- United States Food and Drug Administration Accessed on July 14, 2011
- United States Food and Drug Administration FDA drug safety communication: no increase in risk of cancer with certain blood pressure drugsangiotensin receptor blockers (ARBs) http://www.fda.gov/Drugs/DrugSafety/ucm257516.htm Accessed on July 14, 2011
- FDA Drug Safety Communication: No Increase in Risk of Cancer with Certain Blood Pressure Drugsangiotensin Receptor Blockers (ARBs)

5
- 79952774764
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals J Hypertens 29 2011 623 635
- (2011) J Hypertens , vol.29 , pp. 623-635

6
- 78650703447
- Antihypertensive drugs and risk of cancer: Network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials
- S. Bangalore, S. Kumar, S.E. Kjeldsen, H. Makani, E. Grossman, J. Wetterslev, A.K. Gupta, P.S. Sever, C. Gluud, and F.H. Messerli Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials Lancet Oncol 12 2011 65 82
- (2011) Lancet Oncol , vol.12 , pp. 65-82
- Bangalore, S.¹ Kumar, S.² Kjeldsen, S.E.³ Makani, H.⁴ Grossman, E.⁵ Wetterslev, J.⁶ Gupta, A.K.⁷ Sever, P.S.⁸ Gluud, C.⁹ Messerli, F.H.¹⁰

7
- 79955560688
- Use of angiotensin receptor blockers and the risk of cancer
- B. Pasternak, H. Svanstrom, T. Callreus, M. Melbye, and A. Hviid Use of angiotensin receptor blockers and the risk of cancer Circulation 123 2011 1729 1736
- (2011) Circulation , vol.123 , pp. 1729-1736
- Pasternak, B.¹ Svanstrom, H.² Callreus, T.³ Melbye, M.⁴ Hviid, A.⁵

8
- 39349101029
- Immortal time bias in pharmaco-epidemiology
- S. Suissa Immortal time bias in pharmaco-epidemiology Am J Epidemiol 167 2008 492 499
- (2008) Am J Epidemiol , vol.167 , pp. 492-499
- Suissa, S.¹

9
- 33947227921
- Immortal time bias in observational studies of drug effects
- DOI 10.1002/pds.1357
- S. Suissa Immortal time bias in observational studies of drug effects Pharmacoepidemiol Drug Saf 16 2007 241 249 (Pubitemid 46431687)
- (2007) Pharmacoepidemiology and Drug Safety , vol.16 , Issue.3 , pp. 241-249
- Suissa, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.